Geniposide ameliorates TNBS-induced experimental colitis in rats via reducing inflammatory cytokine release and restoring impaired intestinal barrier function

[1]  A. Basit,et al.  Inflammatory bowel disease: exploring gut pathophysiology for novel therapeutic targets. , 2016, Translational research : the journal of laboratory and clinical medicine.

[2]  Hua Yang,et al.  Aryl Hydrocarbon Receptor Activation in Intestinal Obstruction Ameliorates Intestinal Barrier Dysfunction Via Suppression of MLCK-MLC Phosphorylation Pathway , 2016, Shock.

[3]  H. Abdallah,et al.  Mentha longifolia protects against acetic-acid induced colitis in rats. , 2016, Journal of ethnopharmacology.

[4]  Chunjiang Zhang,et al.  The potential mechanism of Bawei Xileisan in the treatment of dextran sulfate sodium-induced ulcerative colitis in mice. , 2016, Journal of ethnopharmacology.

[5]  T. Bai,et al.  Geniposide acutely stimulates insulin secretion in pancreatic β-cells by regulating GLP-1 receptor/cAMP signaling and ion channels , 2016, Molecular and Cellular Endocrinology.

[6]  M. Bissonnette,et al.  Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitis. , 2016, The American journal of clinical nutrition.

[7]  Ruyan Wu,et al.  Two standardized fractions of Gardenia jasminoides Ellis with rapid antidepressant effects are differentially associated with BDNF up-regulation in the hippocampus. , 2016, Journal of ethnopharmacology.

[8]  Hongwei Chu,et al.  Salvianolic Acid B Restored Impaired Barrier Function via Downregulation of MLCK by microRNA-1 in Rat Colitis Model , 2016, Front. Pharmacol..

[9]  D. Topping,et al.  Polyphenol-Rich Propolis Extracts Strengthen Intestinal Barrier Function by Activating AMPK and ERK Signaling , 2016, Nutrients.

[10]  Lixia Guo,et al.  Geniposide Suppresses Hepatic Glucose Production via AMPK in HepG2 Cells. , 2016, Biological & pharmaceutical bulletin.

[11]  GuoLin Wang,et al.  Hydrogen-Rich Medium Ameliorates Lipopolysaccharide-Induced Barrier Dysfunction via Rhoa-Mdia1 Signaling in Caco-2 Cells , 2016, Shock.

[12]  Wenjian Tang,et al.  Apoptotic Effect of Geniposide on Fibroblast-Like Synoviocytes in Rats with Adjuvant-Induced Arthritis via Inhibiting ERK Signal Pathway In Vitro , 2016, Inflammation.

[13]  L. D. Di Stasi,et al.  Experimental evidence of heparanase, Hsp70 and NF-κB gene expression on the response of anti-inflammatory drugs in TNBS-induced colonic inflammation. , 2015, Life sciences.

[14]  Jie Du,et al.  1,25-Dihydroxyvitamin D Protects Intestinal Epithelial Barrier by Regulating the Myosin Light Chain Kinase Signaling Pathway , 2015, Inflammatory bowel diseases.

[15]  R. D'Incà,et al.  Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut , 2015, Mediators of inflammation.

[16]  Kuei-Wen Chang,et al.  6-Gingerol modulates proinflammatory responses in dextran sodium sulfate (DSS)-treated Caco-2 cells and experimental colitis in mice through adenosine monophosphate-activated protein kinase (AMPK) activation. , 2015, Food & function.

[17]  Guangjie Chen,et al.  Berberine ameliorates TNBS induced colitis by inhibiting inflammatory responses and Th1/Th17 differentiation. , 2015, Molecular immunology.

[18]  K. Mollen,et al.  Mitochondrial dysfunction in inflammatory bowel disease , 2015, Front. Cell Dev. Biol..

[19]  Jin Xiang,et al.  Wild jujube polysaccharides protect against experimental inflammatory bowel disease by enabling enhanced intestinal barrier function. , 2015, Food & function.

[20]  A. Kaye,et al.  Tanshinone IIA Attenuates Chronic Pancreatitis-Induced Pain in Rats via Downregulation of HMGB1 and TRL4 Expression in the Spinal Cord. , 2015, Pain physician.

[21]  Hong Wu,et al.  Determination of geniposide in adjuvant arthritis rat plasma by ultra-high performance liquid chromatography tandem mass spectrometry method and its application to oral bioavailability and plasma protein binding ability studies. , 2015, Journal of pharmaceutical and biomedical analysis.

[22]  Yongyan Shi,et al.  Vitamin D/VDR signaling pathway ameliorates 2,4,6-trinitrobenzene sulfonic acid-induced colitis by inhibiting intestinal epithelial apoptosis , 2015, International journal of molecular medicine.

[23]  Meng-yao Guo,et al.  Geniposide inhibited lipopolysaccharide-induced apoptosis by modulating TLR4 and apoptosis-related factors in mouse mammary glands. , 2014, Life sciences.

[24]  S. Gong,et al.  Effect of Astragalus polysaccharides on expression of TNF-α, IL-1β and NFATc4 in a rat model of experimental colitis. , 2014, Cytokine.

[25]  Jian-Guo Jiang,et al.  Active ingredients from natural botanicals in the treatment of obesity , 2014, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[26]  Hongjuan Liu,et al.  Geniposide attenuates mitochondrial dysfunction and memory deficits in APP/PS1 transgenic mice. , 2014, Current Alzheimer research.

[27]  Xiaoling Li,et al.  Geniposide suppresses LPS-induced nitric oxide, PGE2 and inflammatory cytokine by downregulating NF-κB, MAPK and AP-1 signaling pathways in macrophages. , 2014, International immunopharmacology.

[28]  S. Hirota,et al.  Pregnane X receptor agonists enhance intestinal epithelial wound healing and repair of the intestinal barrier following the induction of experimental colitis. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[29]  Yunhe Fu,et al.  Geniposide Plays an Anti-inflammatory Role via Regulating TLR4 and Downstream Signaling Pathways in Lipopolysaccharide-Induced Mastitis in Mice , 2014, Inflammation.

[30]  Jiahui Yuan,et al.  Ginsenoside Metabolite Compound K Promotes Recovery of Dextran Sulfate Sodium-Induced Colitis and Inhibits Inflammatory Responses by Suppressing NF-κB Activation , 2014, PloS one.

[31]  H. Choi,et al.  Acetylcholine-induced AMP-activated protein kinase activation attenuates vasoconstriction through an LKB1-dependent mechanism in rat aorta. , 2013, Vascular pharmacology.

[32]  C. Abraham,et al.  TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis. , 2013, Gastroenterology.

[33]  F. Tsai,et al.  Inhibition of enterovirus 71 infections and viral IRES activity by Fructus gardeniae and geniposide. , 2013, European journal of medicinal chemistry.

[34]  L. Poisson,et al.  PTEN suppresses SPARC-induced pMAPKAPK2 and inhibits SPARC-induced Ser78 HSP27 phosphorylation in glioma. , 2013, Neuro-oncology.

[35]  J. Xing,et al.  Ameliorative effects of 3,4-oxo-isopropylidene-shikimic acid on experimental colitis and their mechanisms in rats. , 2013, International immunopharmacology.

[36]  B. Viollet,et al.  Inhibition of AMP-activated protein kinase accentuates lipopolysaccharide-induced lung endothelial barrier dysfunction and lung injury in vivo. , 2013, The American journal of pathology.

[37]  H. Choi,et al.  Metformin-induced AMP-activated protein kinase activation regulates phenylephrine-mediated contraction of rat aorta. , 2012, Biochemical and biophysical research communications.

[38]  E. Crouser,et al.  Intestinal epithelium is more susceptible to cytopathic injury and altered permeability than the lung epithelium in the context of acute sepsis , 2011, International journal of experimental pathology.

[39]  T. Shimada,et al.  Preventive effect of geniposide on metabolic disease status in spontaneously obese type 2 diabetic mice and free fatty acid-treated HepG2 cells. , 2011, Biological & pharmaceutical bulletin.

[40]  M. Zwolinska-Wcislo,et al.  Nitric oxide-releasing aspirin but not conventional aspirin improves healing of experimental colitis. , 2011, World journal of gastroenterology.

[41]  Dong-Hyun Kim,et al.  Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation--the key step of inflammation. , 2011, Biochemical pharmacology.

[42]  P. Habibollahi,et al.  Chronic lithium administration ameliorates 2,4,6‐trinitrobenzene sulfonic acid‐induced colitis in rats; potential role for adenosine triphosphate sensitive potassium channels , 2011, Journal of gastroenterology and hepatology.

[43]  Dong-Hyun Kim,et al.  Kalopanaxsaponin A ameliorates experimental colitis in mice by inhibiting IRAK‐1 activation in the NF‐κB and MAPK pathways , 2011, British journal of pharmacology.

[44]  C. Bernstein,et al.  AMPK agonist downregulates innate and adaptive immune responses in TNBS-induced murine acute and relapsing colitis. , 2010, Biochemical pharmacology.

[45]  J. Calixto,et al.  The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice , 2008, Journal of leukocyte biology.

[46]  E. Abraham.  NF-kappaB activation. , 2000, Critical care medicine.